Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
filingDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017501191-A |
titleOfInvention |
Novel imidazolidine-2,4-dione derivatives |
abstract |
The subject of the present invention is a novel imidazolidine-2,4-dione derivative of general formula (I). These substances have antiproliferative activity. They are particularly useful for treating pathological conditions or diseases associated with abnormal cell growth such as cancer. The invention also relates to pharmaceutical compositions containing said substances and their use for the preparation of a medicament. |
priorityDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |